Skip to main content
Premium Trial:

Request an Annual Quote

Merck’s $1.1B Acquisition of Sirna Could Close by End of Year

NEW YORK (GenomeWeb News) — Merck today said that its acquisition of RNAi shop Sirna Therapeutics may close as early as this month.
 
Merck announced its plans to acquire Sirna for $1.1 billion in cash on Oct. 30. At the time, the company said it expected the deal to close by the first quarter of 2007.
Today Merck said it expects the deal to close “in late December 2006 or early in the first quarter of 2007.”
 
The acquisition must still be approved by Sirna's shareholders and other conditions. Sirna shareholders are expected to vote on the deal on Dec. 28.
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.